2018 National Cancer Institute Director’s Award for Network Accrual Core Team (Network ACT)
Westat received the National Cancer Institute’s (NCI’s) Director's Award for the Network Accrual Core Team (Network ACT) and promoting collaborations on November 8, 2018.
The honor spotlights Westat researchers’ work with the NCI's National Cancer Trials Network (NCTN) and Community Oncology Research Program (NCORP). It recognizes Westat’s work, “for outstanding leadership and teamwork to collaboratively address accrual barriers to NCTN and NCORP clinical trials,” according to NCI.
The award is for the Cancer Trials Support Unit (CTSU) team’s contributions to coordinating and participating in the Network ACT. The team includes NCI staff and Vinita Gotting, Martha Hering, Lena Muwakki, Carl Riley, and Demetrius Williams from Westat.
Network ACT aims to
- Increase cross-Network awareness of NCTN-sponsored clinical trials
- Provide a forum to discuss challenging studies
- Address accrual issues across the NCTN and NCORP
The CTSU is a service of NCI designed to
- Facilitate access to NCI-funded clinical trials for qualified clinical sites
- Support the management and conduct of those clinical trials
Learn more about Westat and how we are helping NCI’s CTSU.